Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry

摘要

Objective. To describe the outcomes of MTX and biologic DMARD (bDMARD) treatment in patients with RA and assess unmet needs in patients who fail treatment, using real-world data from the Norwegian DMARD (NOR-DMARD) registry.